Abstract
Introduction
To explore new GAPDH functions in E. coli, in this study we conducted in vivo 114 formaldehyde cross-linking experiments followed by MS to identify proteins interacting 115 with V5-tagged GAPDH in E. coli. We also characterized interaction with 116 phosphoglycolate phosphatase (Gph), an enzyme involved in the metabolism of 2-117 phosphoglycolate, a compound formed in the DNA repair of 3'-phosphoglycolate ends 118 generated by bleomycin damage (Pellicer et al., 2003) . 119 120 121
Materials and methods 122 123

Bacterial strains and growth conditions 124
The genotypes and sources of the E. coli strains used in this study are as follows. Strain 125 MC4100 (F -araD ∆(argF-lac) rpsL(Str r ) relA fihD deoC ptsF rbs) (Casadaban, 1976) was 126 the source of chromosomal DNA used as a template for PCR amplification of gene gapA. 127
The mutant strain JA210 (gph::Kan) was derived from MC4100 (Pellicer et al., 2003) . (TTTGGA GATGTGAGCGATCAGG). To express GAPDH with its native N-terminal 159 end (without the N-terminal leader), the forward primer was designed with an in-frame stop 160 codon (TAG, underlined) at the 5'-end followed by the native gapA sequence including the 161 ribosome binding site and the start codon (in bold). The gapA stop codon was removed 162 from the reverse primer to allow expression of GAPDH fused at its C-terminal end to the 163 V5 epitope. The PCR fragment was cloned into plasmid pBAD-TOPO (Invitrogen) and 164 after transformation of strain TOP10, recombinant colonies were selected on LB-ampicillin 165 plates. Plasmid DNA was sequenced to ensure that the fragment was inserted in the correct 166 orientation and that no mutations were introduced. The recombinant plasmid was named 167 pBAD-GapA. 168 169
In vivo cross-linking with formaldehyde 170
Cells of strain TOP10 bearing the recombinant plasmid pBAD-GapA were grown at 171 37ºC in 10 ml of LB-ampicillin until the culture reached an OD 600 of 0.5. At this point L-172 arabinose was added at a final concentration of 0.02% to induce the expression of GAPDH-173 V5. After a 3 h induction, formaldehyde was added at a final concentration of 1%. 174
Formaldehyde cross-linking was allowed to proceed for 20 min at 37ºC. To stop the cross-175 linking reaction, glycine was added at a final concentration of 0.5 M and after 5 min at 176 room temperature, bacterial cells were harvested by centrifugation, washed twice with PBS 177 (140 mM NaCl, 2.7 mM KCl, 10 mM Na 2 HPO 4 , 1.8 mM KH 2 PO 4 , pH 7.3), and 178 resuspended in 0.4 ml of PBS containing a cocktail of protease inhibitors (Roche9 Diagnostic). Cell extracts were obtained by sonic disruption of bacterial cells followed by 180 centrifugation to remove cell debris. Protein concentration was determined using the 181 method described by Lowry et al. (1951) with bovine serum as a standard. 182 ml with PBS buffer and incubated with anti-V5 beads as described above. Recombinant GAPDH and Gph were expressed and purified using the Glutathione-S-236 transferase (GST) gene fusion system with recognition sites for factor Xa cleavage as 237 Binding of GAPDH to Gph was analysed by Far-Western assays (overlay 268 immunoblotting). In this case, purified GAPDH was subjected to 2D gel electrophoresis as 269 described above. After being blocked overnight with 1% gelatin in TBS buffer, the 270 membrane was incubated with purified Gph (5 µg/ml) diluted in the same blocking bufferfor 3 hours and then washed four times in TBS-0.05% Tween-20. To visualize interaction 272 of GAPDH with Gph, the membrane was incubated with anti-Gph specific antibodies 273
(1:5,000 dilution TBS-1% gelatin-0.05% Tween-20) for 16 h at 4ºC, and processed as 274 described above using the ECL Western blotting kit to visualize the reactive spots. The 275 incubation step with purified Gph was omitted as negative control. 276
The anti-Gph antibodies used in this study were purified by affinity chromatography. 277
For this purpose, purified Gph was covalently linked to Ultralink 
Immunoaffinity purification of proteins cross-linked to GAPDH-V5 and their 302 identification by mass spectrometry 303
Cultures of TOP10 cells expressing V5-tagged GAPDH were treated with 304 formaldehyde and the GAPDH-V5 containing complexes were analysed in the cell extracts 305
by Western blotting with either anti-V5 or anti-GAPDH antibodies. As control, TOP10 306 cells without the recombinant pBAD-GapA plasmid were processed in parallel. As shown 307
in Fig. 1A , protein bands ranging in size from 70 kDa to 160 kDa were only detected above 308 recombinant GAPDH-V5 (37 kDa) in cells treated with the cross-linker. The most apparent 309 bands corresponded to high molecular protein complexes in accordance with the native 310 GAPDH tetramer structure. The presence of protein complexes with a molecular mass 311 lower than 160 kDa indicates that other oligomeric or monomeric GAPDH-V5 forms were 312 being cross-linked with E. coli proteins. To set up the conditions for cross-linking reversal, 313 cell extracts were incubated at 65ºC or 95ºC in loading buffer and at the indicated times, 314 reversion of the cross-links was analysed by Western blotting with anti-V5 antibodies (Fig.  315   1B) . The high molecular mass complexes produced by formaldehyde treatment were no 316 longer detected after 30 min incubation at 95ºC. These conditions were selected for further 317 experiments. 318
In order to identify the proteins that were cross-linked to GAPDH-V5, precleared 319 cell extracts obtained from TOP10 (pBAD-GapA) cells challenged with formaldehyde were 320 incubated with anti-V5 beads. After astringent washing steps, bound material was eluted as 321 described in section 2.5. Cell extracts obtained from non formaldehyde-treated TOP10 322 (pBAD-GapA) cells were processed in parallel. Purified complexes were concentrated by 323 acetone precipitation, resuspended in loading buffer and processed to reverse formaldehyde 324 cross-links. Proteins were separated by SDS-PAGE. Staining with Sypro® Ruby revealed 325 several proteins in the cross-linked sample that were not visible in the lane corresponding to 326 non-treated cells (Fig. 2) . These differential proteins were selected for further analysis. In 327 the absence of formaldehyde treatment, co-purification of native GAPDH (band 2) with 328 recombinant GAPDH-V5 (band 3) under astringent conditions (Fig. 2, -FA Twelve major bands were excised from the cross-linked sample ( 
Identification of proteins that co-purify with GAPDH-V5 in the absence of cross-367 linking 368
Immunoprecipitation experiments with anti-V5 agarose beads were also carried out 369 to identify proteins that interact with GAPDH without previous cross-linking. Precleared 370 cell extracts were processed as described in section 2.5. Purified proteins were concentrated 371 by TCA precipitation, resuspended in rehydration buffer and processed for 2D gel 372 electrophoresis. In addition to the dominant spots corresponding to recombinant GAPDH-373 V5 and native GAPDH forms, staining with Sypro® Ruby also revealed other proteins that 374 co-purified with GAPDH-V5 under these conditions (Fig. 2B ). An immunoprecipitation 375 experiment starting with precleared cell extracts of TOP10 cells was performed as control. 376
In the absence of a V5-tagged protein, no apparent spots were visible (not shown), thus 377 ruling out co-purification of these proteins through interactions with the affinity matrix. 378
Ten spots were excised from the 2D gel (Fig. 2B ) and analysed by LC-MS/MS, in 379 this case using a high sensitivity OrbitrapVelos mass spectrometer that enables 380 identification of proteins even at very low amounts. Results are summarized in Table 2 . 381 Among these proteins, the ATP synthase β subunit (AtpD) and the porin OmpC, both 382 displaying high scores in this analysis, were also identified as proteins interacting with 383 GAPDH after formaldehyde cross-linking (Table 1) . Regarding the ATP synthase α subunit 384 (AtpA) and LpdA (both in spot 1), although these proteins were not listed in Table 1 , the 385 MS analysis performed in the cross-linking experiment revealed in both cases two peptides 386 matching these sequences. Another protein found here to co-purify with GAPDH was GatY 387 identified as interacting with GAPDH in the cross-linking experiment. However, it should 391 be noted that in this experiment, only proteins specifically present in the FA-treated sample 392 were excised and analysed by MS. In this sense, GatY should correspond to one of the non-393 excised protein bands with a molecular mass around 30 kDa, also visible in the control 394 sample (Fig. 1A lane -FA versus +FA) . 395
The protein displaying the highest score in this analysis was AtpD, with 40 peptides 396 identified that covered 85.87% of the sequence (Table 2 ). This ATP synthase subunit 397 interacts with the α subunit (AtpA) to form the catalytic domain for ATP synthesis. AtpA 398 also co-purified with GAPDH-V5, although the MS analysis yielded a lower score. In this 399 case, 29 peptides were identified that covered 61.79 % of the sequence (Table 2) . 400
To validate interaction of GAPDH with both ATP synthase subunits, pull-down 401 experiments with His 6 -tagged AtpD and AtpA proteins were performed. Recombinant His 6 -402 AtpD and His 6 -AtpA were expressed and purified from the ASKA clones JW3710 and 403 JW3712, respectively, as described in section 2.7. Immunoblotting of the column fractions 404 with anti-GAPDH antibodies indicated that a fraction of GAPDH was bound and co-eluted 405 with either His 6 -AtpD or His 6 -AtpA (Fig. 3) . In a control experiment, the cell extract 406 obtained from the host strain AG1 was directly applied to the Ni 2+ -NTA column and 407 processed in parallel as a control to confirm that the Ni 2+ -NTA resin did not bind GAPDH 408 to any extent (Fig. 3, right panel) . It is noteworthy that even at lower bait protein 409 concentration the GAPDH fraction recovered in these experiments was higher in the case ofindirect through its interaction with the AtpD subunit. Alternatively, association of the 412 AtpD and AtpA may be required to provide the interaction domain with GAPDH. 413
It should be noted that in addition to AtpA, spot 1 contained other ATP-binding 414 proteins such as AraG and RbsA. Abundance of these proteins in the spot should be very 415 low given the low score and number of sequenced peptides (Table 2 ). Their identification 416 may be attributed to the high sensitivity achieved with the analysis through use of the 417 OrbitrapVelos mass spectrometer. All the proteins identified in spot 1 displayed similar 418 molecular mass and pI, which is compatible with their inclusion in a single spot (Table 2) . 419
The fact that out of these five proteins, three contained ATP-binding domains suggests that 420 GST-Gph but not with GST (Fig. 4A) . In a parallel experiment, elution of Gph from the 455 affinity resin was achieved by incubation with factor Xa. Western blot analysis confirmed 456 co-elution of GAPDH (Fig. 4B) . In the eluted fractions, in addition to Gph (27 kDa), two 457 other proteins were visible. The 34 kDa protein is one of the factor Xa subunits. The 35down experiments using His 6 -Gph expressed in strain AG1 from the ASKA clone JW3348 460 as bait confirmed co-purification of GAPDH with Gph (not shown). 461
Overall these results confirmed interaction of GAPDH with Gph. However, when 462 purified GAPDH was applied to an immobilized GST-Gph column, GAPDH was scarcely 463 retained (not shown). Most of the GAPDH protein appeared in the flow-through fraction, 464
suggesting that interaction between these proteins may either depend on other cellular 465 factors (proteins or ligands) or on post-translational modifications of these proteins. purified GAPDH was subjected to 2D gel electrophoresis. Once electroblotted, the 470 membrane was reacted with purified Gph followed by incubation with specific anti-Gph 471 antibodies. Of the multiple GAPDH spots, only one was visualized (Fig. 3C) , indicating 472 that Gph mainly interacts with a specific form of GAPDH. These results provide evidence 473 of a direct interaction between both proteins, and indicate that it depends on a given post-474 translational modification of GAPDH. 475
Since human GAPDH has been shown to be involved in repairing the DNA damage 476 generated by bleomycin or alkylating agents (Azam et al., 2008) , we examined whether 477
Gph-GAPDH interacting complexes increased in cells challenged with bleomycin. To this 478 end, induced exponential cultures of the gph mutant strain JA210 harbouring plasmid 479 pGEX-Gph were treated with 8 µg/ml bleomycin in the presence of 50 µM FeSO 4, 480 conditions that increase the number of DNA strand breaks to be repaired. At different 481 times, aliquots of the culture were collected and processed to obtain the cell extracts. After 482 30 min exposure to bleomycin, the percentage of viable cells was found to be around 30%. 483
Cell extracts were incubated with glutathione-sepharose 4B resin in PBS buffer. After 484 extensive washing, GST-Gph was eluted with SDS-PAGE loading buffer. To evaluate 485 GAPDH association, fractions were analysed by Western blotting with antibodies against 486 GAPDH. For normalization, the same fractions were analysed in parallel with anti-GST 487 antibodies (Fig. 5) . In these experiments, the total amount of protein applied to the 488 electrophoresis gel was lower than that used in the pull-down experiments presented in 
